First stage of Almac expansion complete

Almac Sciences has completed the first stage of its GMP API facility expansion at its headquarters site in Craigavon, Northern Ireland. This has seen two 1,000 L glass-lined reactors added with associated filtration and drying equipment allowing the manufacture of 50-100 kg batch API output. It complements the R&D technology centre opened in 2021 for the biocatalysis, flow chemistry and peptides businesses.

The company described this as the latest stage of a multi-million-pound investment programme to support increased manufacturing demands.  The programme will create manufacturing centres of excellence to support small molecule API production at up to 200-300 kg scale, as well as increased capacity for peptide API production.

Active recruitment to fill production technician, engineering and QA positions and the next phase of development are both now under way. Further manufacturing and warehousing expansions will be announced in due course, the company added.